Fri, Nov 28, 2014, 3:50 AM EST - U.S. Markets open in 5 hrs 40 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • xtradersdotnet xtradersdotnet Dec 7, 2012 1:07 PM Flag

    Canacord update...

    In a report published Friday, Canaccord Genuity reiterated its Buy rating on Amarin Corporation (NASDAQ: AMRN), but lowered its price target from $26.00 to $19.00 .
    Canaccord Genuity noted, “Reiterate BUY, lowering target to $19 ; maintain positive view on Vascepa commercial, partnering potential while acknowledging increased commercial risk. We continue to expect business development talks to intensify and Vascepa to receive NCE (five-year exclusivity). Our $19 target is based on a sum-of-the-parts analysis, combining a DCF of high triglyceride sales and pNPV of mixed dyslipidemia sales.”
    Amarin Corporation closed on Thursday at $11.95 .

 
AMRN
1.26+0.040(+3.28%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.